Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 USD | +9.68% | -0.97% | -15.00% |
Financials (USD)
Sales 2024 * | 1.1B | Sales 2025 * | 1.13B | Capitalization | 97.45M |
---|---|---|---|---|---|
Net income 2024 * | -83M | Net income 2025 * | 66M | EV / Sales 2024 * | 0.23 x |
Net Debt 2024 * | 156M | Net Debt 2025 * | 402M | EV / Sales 2025 * | 0.44 x |
P/E ratio 2024 * |
-1.15
x | P/E ratio 2025 * |
1.28
x | Employees | 1,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent BioSolutions Inc.
1 day | +9.68% | ||
1 week | -0.97% | ||
Current month | -19.37% | ||
1 month | -17.07% | ||
3 months | +11.48% | ||
6 months | -8.11% | ||
Current year | -15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 62 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 27 M€ | -5.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 2.04 | +9.68% | 924,755 |
24-04-18 | 1.86 | -2.11% | 1,061,154 |
24-04-17 | 1.9 | -2.56% | 692,033 |
24-04-16 | 1.95 | -1.52% | 859,265 |
24-04-15 | 1.98 | -3.88% | 1,248,734 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.00% | 97.45M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- EBS Stock